| Chlorocebus sabaeus |
Vero 76 |
IC50 |
1300.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Ebolavirus |
Ebolavirus |
IC50 |
820.0 |
nM |
10.1021/acsmedchemlett.0c00298 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CaM kinase I alpha |
Inhibition |
35.0 |
% |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cathepsin D |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
6200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
25999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEK293 |
CC50 |
3549.5 |
nM |
10.1021/acs.jmedchem.8b01310 |
| Homo sapiens |
HEK293 |
GI |
95.6 |
% |
10.1021/acs.jmedchem.8b01310 |
| Homo sapiens |
HEK293 |
GI |
102.0 |
% |
10.1021/acs.jmedchem.8b01310 |
| Homo sapiens |
HEK293 |
IC50 |
1.79 |
nM |
10.1021/acs.jnatprod.5b00581 |
| Homo sapiens |
HEK293 |
IC50 |
1800.0 |
nM |
10.1021/acs.jnatprod.6b00759 |
| Homo sapiens |
HEK293 |
IC50 |
1800.0 |
nM |
10.1021/acs.jnatprod.9b00721 |
| Homo sapiens |
HEK293 |
IC50 |
1990.0 |
nM |
10.1021/acs.jnatprod.8b00956 |
| Homo sapiens |
HEK293 |
IC50 |
2900.0 |
nM |
10.1021/acs.jnatprod.7b00587 |
| Homo sapiens |
HEK293 |
IC50 |
5200.0 |
nM |
10.1021/acs.jnatprod.8b00154 |
| Homo sapiens |
HEK293 |
IC50 |
5220.0 |
nM |
10.1016/j.bmcl.2017.03.065 |
| Homo sapiens |
HeLa |
IC50 |
3100.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
HERG |
AC50 |
280.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
7.32 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
9.93 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HT-1080 |
IC50 |
4230.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Jurkat |
IC50 |
4000.0 |
nM |
10.1021/jm00036a014 |
| Homo sapiens |
Jurkat |
TI |
1480.0 |
None |
10.1021/jm00036a014 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Maternal embryonic leucine zipper kinase |
Inhibition |
31.0 |
% |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
25000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
25999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
8100.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2004.05.099 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
5699.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
23999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
17100.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SH-SY5Y |
Activity |
nan |
None |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
SH-SY5Y |
IC50 |
1700.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
SK-N-AS |
IC50 |
3450.0 |
nM |
10.1016/j.bmc.2022.117043 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
17999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
5.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.112175 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
50.0 |
% |
10.1021/jm400325j |
| Plasmodium falciparum |
Hemozoin |
IC50 |
2200.0 |
nM |
10.1021/acs.jmedchem.0c02022 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
16.0 |
nM |
10.1021/acs.jmedchem.6b01673 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
25.0 |
nM |
10.1021/acs.jmedchem.6b01673 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
53.0 |
nM |
10.1016/j.ejmech.2021.113253 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
94.0 |
nM |
10.1021/acs.jmedchem.0c02022 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
1240.0 |
nM |
10.1016/j.ejmech.2021.113253 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
1400.0 |
nM |
10.1021/acs.jmedchem.6b01673 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
3108.0 |
nM |
10.1021/acs.jmedchem.6b00723 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
0.8 |
nM |
10.1021/jm00036a014 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.0 |
nM |
10.1021/jm00036a014 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.6 |
nM |
10.1128/aac.00801-10 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1.92 |
nM |
10.1128/aac.00801-10 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
2.7 |
nM |
10.1021/jm00036a014 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3.2 |
nM |
10.6019/CHEMBL2113921 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3.6 |
nM |
10.1021/acs.jnatprod.5b00581 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3.6 |
nM |
10.1021/acs.jnatprod.6b00759 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3.6 |
nM |
10.1021/acs.jnatprod.9b00721 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5.7 |
nM |
10.1007/s00044-007-9025-8 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6.0 |
nM |
10.1021/jm3005898 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.0 |
nM |
10.1021/acs.jmedchem.8b01310 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.4 |
nM |
10.1016/j.ejmech.2021.113518 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.5 |
nM |
10.1021/acs.jnatprod.6b00759 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.5 |
nM |
10.1021/acs.jnatprod.9b00721 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.51 |
nM |
10.1021/acs.jnatprod.5b00581 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7.9 |
nM |
10.1021/acs.jmedchem.8b01310 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
8.0 |
nM |
10.1128/aac.00801-10 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
8.2 |
nM |
10.1021/acs.jnatprod.8b00956 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
8.3 |
nM |
10.1016/j.ejmech.2021.113518 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
9.1 |
nM |
10.1007/s00044-007-9025-8 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
11.0 |
nM |
10.1021/acs.jnatprod.8b00956 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
11.9 |
nM |
10.1016/j.bmcl.2017.03.065 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12.0 |
nM |
10.1021/acs.jnatprod.7b00587 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12.0 |
nM |
10.1021/acs.jnatprod.8b00154 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
18.0 |
nM |
10.1016/j.bmcl.2017.03.065 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
18.0 |
nM |
10.1021/acs.jnatprod.8b00154 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
20.0 |
nM |
10.1021/jm3005898 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
23.0 |
nM |
10.1021/jm3005898 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
29.0 |
nM |
10.1016/j.ejmech.2018.09.018 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
46.0 |
nM |
10.1021/jm4004279 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
131.3 |
nM |
10.1021/jm4004279 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
140.0 |
nM |
10.1021/acs.jnatprod.7b00587 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1300.0 |
nM |
10.1021/jm4004279 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1710.0 |
nM |
10.1016/j.ejmech.2018.09.018 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
2700.0 |
nM |
10.1016/j.ejmech.2014.05.050 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
2960.0 |
nM |
10.6019/CHEMBL2113921 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
64000.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC99 |
27.0 |
nM |
10.1021/jm00036a014 |
| Plasmodium falciparum |
Plasmodium falciparum |
Inhibition |
50.0 |
% |
10.1021/jm400325j |
| Plasmodium malariae |
Plasmodium malariae |
IC50 |
4.1 |
nM |
10.1128/aac.01122-10 |
| Plasmodium malariae |
Plasmodium malariae |
IC50 |
7.8 |
nM |
10.1128/aac.01122-10 |
| Plasmodium vivax |
Plasmodium vivax |
IC50 |
2.4 |
nM |
10.1128/aac.00801-10 |
| Plasmodium vivax |
Plasmodium vivax |
IC50 |
2.5 |
nM |
10.1128/aac.00801-10 |
| Plasmodium vivax |
Plasmodium vivax |
IC50 |
2.58 |
nM |
10.1128/aac.00801-10 |
| Plasmodium vivax |
Plasmodium vivax |
IC50 |
4.7 |
nM |
10.1128/aac.00801-10 |
| Plasmodium yoelii |
Plasmodium yoelii |
IC50 |
1000.0 |
nM |
10.1021/jm400325j |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.01775 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
Heme |
IC50 |
64000.0 |
nM |
10.1007/s00044-007-9025-8 |
| None |
NON-PROTEIN TARGET |
IC50 |
0.72 |
nM |
10.1128/aac.01122-10 |
| None |
NON-PROTEIN TARGET |
Potency |
23.7 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2022.117043 |
| None |
Unchecked |
Kd |
7340.0 |
nM |
10.1021/acsmedchemlett.0c00298 |
| None |
Unchecked |
Ratio CC50/IC50 |
507.0 |
None |
10.1021/acs.jmedchem.8b01310 |
| None |
Unchecked |
Ratio IC50 |
1.1 |
None |
10.1016/j.ejmech.2021.113518 |
| None |
Unchecked |
Ratio IC50 |
1.3 |
None |
10.1021/acs.jnatprod.8b00956 |
| None |
Unchecked |
Ratio IC50 |
239.0 |
None |
10.1021/acs.jnatprod.7b00587 |
| None |
Unchecked |
Ratio IC50 |
246.1 |
None |
10.1021/acs.jnatprod.8b00956 |
| None |
Unchecked |
Ratio IC50 |
494.5 |
None |
10.1021/acs.jnatprod.6b00759 |
| None |
Unchecked |
Ratio IC50 |
494.5 |
None |
10.1021/acs.jnatprod.9b00721 |